GNRH1 and endometriosis: As a result, it was assumed that dienogest or other progestins would have a positive impact on the clinical outcomes of IVF‐ET, as GnRH agonist, by suppressing endometriosis lesions, inflammatory cytokine levels, and oxidative stress.14, 24